gliptin and glp-1 The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect Prescribing pearls: A guide to
Description
Our sister site, BenefitsPRO, looks at the tough balancing act for HR leaders

Previously, generic was only available in diabetes doses

Results Each propensity-score matched group constituted 3424 patients, 45% women, 21% had a history of cardiovascular disease, and 13.9% were treated with sodium-glucose cotransporter-2 inhibitors at baseline

How she got into practice and how she got into the GLP-1 space

Individual response varies based on metabolism, genetics, and starting dose